Product Name
VAPB, Monoclonal Antibody
Popular Item
Full Product Name
VAPB (Vesicle-associated Membrane Protein-associated Protein B/C, VAMP-B/VAMP-C, VAMP-associated Protein B/C, VAP-B/VAP-C, UNQ484/PRO983)
Product Synonym Names
Anti -VAPB (Vesicle-associated Membrane Protein-associated Protein B/C, VAMP-B/VAMP-C, VAMP-associated Protein B/C, VAP-B/VAP-C, UNQ484/PRO983)
Product Gene Name
anti-VAPB antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 20; NC_000020.10 (56964175..57026157). Location: 20q13.33
3D Structure
ModBase 3D Structure for O95292
Specificity
Recognizes human VAP-B. Species sequence homology: recombinant rat VAP-B (50%). Does not react with recombinant human VAP-A.
Purity/Purification
Purified by Protein A affinity chromatography.
Form/Format
Supplied as a lyophilized powder in PBS, pH 6.4, 5% trehalose. Reconstitute with 200 ul sterile PBS.
Immunogen
Recombinant corresponding to aa2-132 from human VAP-B expressed in E.coli.
Preparation and Storage
Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-VAPB antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-VAPB antibody
Vesicle-associated membrane protein associated protein B is an~30kD ubiquitously expressed type IV transmembrane protein belonging to the VAP family. It is found in endoplasmic reticulum (ER), Golgi and other membranes as a homodimer or a heterodimer with VAP-A, probably associating through a GxxxG motif in the transmembrane regions. Human VAP-B cDNA encodes 243aa that include a 222aa cytoplasmic domain and a 21aa C-terminal membrane anchor. The cytoplasmic domain contains a mobile sperm protein (MSP) domain aa7-124 and a coiled-coil region aa159-196. Human VAP-B shares 90%, 89%, 96%, 96% and 94% aa identity with mouse, rat, canine, bovine and porcine VAP-B, respectively. VAP-A and VAP-B MSP domains recruit FFAT motif-containing proteins to the cytosolic surface of ER membranes. FFAT proteins mediate many of the effects of VAPs on regulation of membrane transport, phospholipid biosynthesis, microtubule organization, and the unfolded protein response. VAPs also interact with some SNARE and viral proteins. A human polymorphism of VAP-B, P56S, is found in three familial motor neuron diseases, notably the amylotrophic lateral sclerosis variant ALS8. It produces a non-functional protein that can dimerize with and inhibit function of normal VAP-B, leading formation of intracellular aggregates and increased ER-stress-induced death of motor neurons. It can also promote cleavage and secretion of soluble VAP-B, which can then function as a ligand for EPH receptors. A naturally occurring 99aa isoform of VAP-B that diverges at 71aa within the MSP domain is termed VAP-C. It also appears to be a negative regulator of VAP-A and VAP-B. While VAP-B is used by hepatitis C virus (HCV) for its propagation, VAP-C inhibits HCV propagation.
Product Categories/Family for anti-VAPB antibody
Antibodies; Abs to Membrane Proteins
Applications Tested/Suitable for anti-VAPB antibody
Immunohistochemistry (IHC)
Application Notes for anti-VAPB antibody
Suitable for use in Immunohistochemistry.
Dilution: Immunohistochemistry: 8-25ug/ml using immersion fixed paraffin-embedded sections of human brain (cerebellum)
Optimal dilutions to be determined by the researcher.
Test Data of anti-VAPB antibody
VAP-B in Human Brain. VAP-B was detected in immersion fixed paraffin-embedded sections of human brain (cerebellum) using MBS6011828 at 15ug/ml overnight at 4 degree C. Tissue was stained using the Mouse HRP-DAB specific staining was localized to neuronal cell bodies.

NCBI/Uniprot data below describe general gene information for VAPB. It may not necessarily be applicable to this product.
NCBI Accession #
AAQ88829.1
[Other Products]
UniProt Primary Accession #
O95292
[Other Products]
UniProt Secondary Accession #
O95293; Q9P0H0; A2A2F2[Other Products]
UniProt Related Accession #
O95292[Other Products]
Molecular Weight
27,228 Da[Similar Products]
NCBI Official Full Name
VAPB
NCBI Official Synonym Full Names
VAMP (vesicle-associated membrane protein)-associated protein B and C
NCBI Official Symbol
VAPB [Similar Products]
NCBI Official Synonym Symbols
ALS8; VAP-B; VAMP-B
[Similar Products]
NCBI Protein Information
vesicle-associated membrane protein-associated protein B/C; VAMP-associated 33 kDa protein
UniProt Protein Name
Vesicle-associated membrane protein-associated protein B/C
Protein Family
Virulence-associated protein
UniProt Gene Name
VAPB [Similar Products]
UniProt Synonym Gene Names
VAMP-B/VAMP-C; VAMP-associated protein B/C; VAP-B/VAP-C [Similar Products]
UniProt Entry Name
VAPB_HUMAN
NCBI Summary for VAPB
The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
UniProt Comments for VAPB
VAPB: Participates in the endoplasmic reticulum unfolded protein response (UPR) by inducing ERN1/IRE1 activity. Involved in cellular calcium homeostasis regulation. Defects in VAPB are the cause of amyotrophic lateral sclerosis type 8 (ALS8). ALS8 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms. Defects in VAPB are a cause of spinal muscular atrophy proximal ***** autosomal dominant (SMAPAD); also called late-onset spinal muscular atrophy Finkel type. A form of spinal muscular atrophy, a neuromuscular disorder characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMAPAD is characterized by proximal muscle weakness that begins in the lower limbs and then progresses to upper limbs, onset in late *****hood (after third decade) and a benign course. Most of the patients remain ambulatory 10 to 40 years after clinical onset. Belongs to the VAMP-associated protein (VAP) (TC 9.B.17) family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral
Chromosomal Location of Human Ortholog: 20q13.33
Cellular Component: Golgi membrane; Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum; integral to membrane
Molecular Function: protein binding; enzyme binding; protein homodimerization activity; FFAT motif binding; protein heterodimerization activity; microtubule binding; beta-tubulin binding
Biological Process: endoplasmic reticulum organization and biogenesis; cellular calcium ion homeostasis; ER to Golgi vesicle-mediated transport; positive regulation of viral genome replication; sphingolipid metabolic process; unfolded protein response, activation of signaling protein activity; sphingolipid biosynthetic process; unfolded protein response; virus-host interaction; negative regulation of viral protein levels in host cell
Disease: Spinal Muscular Atrophy, Late-onset, Finkel Type; Amyotrophic Lateral Sclerosis 8
Research Articles on VAPB
1. this discovery provides a mechanism for ALS-causing VAPB mutants/variants to gain novel functions such as to mediate ER structure before significant accumulation of aggregates occurs.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.